NCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Recruiting now NA Last updated 13 May 2025

What this trial tests

NA trial testing Short and Intensive Treatment in Obsessive-Compulsive Disorder in 100 participants. Currently enrolling.

Timeline

1 January 2021

Primary endpoint
31 December 2028

31 December 2028

Quick facts

Lead sponsor	Susanne Walitza
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 January 2021
Primary completion	31 December 2028
Estimated completion	31 December 2028
Sites	1 location across Switzerland

Drugs / interventions tested

• Short and Intensive Treatment

Conditions studied

• Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →

Sponsor

Susanne Walitza

Who can join

Adults 8 to 18, any sex, with Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%, they are among the most common psychiatric disorders in children and adolescents. 40% of diagnosed children and young adults display persistent and increasingly chronic symptoms and O-C disorders are highly complex syndromes with broadly varying manifestations. They arise from obsessive thoughts (ideas/thoughts or impulses, often senseless or tortured, that impose themselves or intrude) and obsessive behavior (ritualized patterns that must be frequently repeated).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.